Platte River Wealth Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History

Platte River Wealth Advisors’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	$403K	Hold	383	–	–	0.11%	72
2024 Q2	$403K	Hold	383	–	–	0.11%	70
2024 Q1	$369K	Hold	383	–	–	0.11%	76
2023 Q4	$336K	Sell	383 -5	-1%	-$4.12K	0.11%	82
2023 Q3	$319K	Hold	388	–	–	0.12%	79
2023 Q2	$279K	Hold	388	–	–	0.1%	84
2023 Q1	$319K	Hold	388	–	–	0.12%	74
2022 Q4	$280K	Hold	388	–	–	0.12%	77
2022 Q3	$267K	Hold	388	–	–	0.12%	77
2022 Q2	$229K	Hold	388	–	–	0.1%	80
2022 Q1	$271K	Hold	388	–	–	0.1%	78
2021 Q4	$243K	Sell	388 -160	-29%	-$98.4K	0.08%	81
2021 Q3	$332K	Buy	548 +172	+46%	+$107K	0.12%	75
2021 Q2	$210K	Buy	+376	New	+$190K	0.08%	87
2020 Q3	–	Sell	-472	Closed	-$296K	–	88
2020 Q2	$296K	Buy	+472	New	+$268K	0.16%	76

Other funds holding REGN

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Platte River Wealth Advisors's REGN Position: Q3 2024 in Review

Platte River Wealth Advisors held its Regeneron Pharmaceuticals (REGN) position steady in Q3 2024 at 383 shares worth $403K. The position accounts for 0.11% of the portfolio, ranked #72.

Platte River Wealth Advisors first reported a position in REGN in Q2 2020 and has held it in 15 quarters since. 1,389 funds tracked by Wall St. Rank hold REGN as of Q3 2024.

Platte River Wealth Advisors held 383 shares of Regeneron Pharmaceuticals worth $403K as of Q3 2024.
Platte River Wealth Advisors left its Regeneron Pharmaceuticals share count unchanged in Q3 2024.
Regeneron Pharmaceuticals made up 0.11% of Platte River Wealth Advisors's portfolio in Q3 2024, its #72 holding.
Platte River Wealth Advisors first reported a position in Regeneron Pharmaceuticals in Q2 2020 and has held it in 15 quarters since.
1,389 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2024.

Based on Platte River Wealth Advisors's 13F filing for Q3 2024, filed 7 Oct 2024.